As showed in Figure 6, we found higher GALE, RPL39L, PCDHB3, GUCA1A, MICALL2, SLC35G5, MGMT, TSPAN4, NOL3 and NLRP12 expression are correlated with poor overall survival in GBM patients (Figure 6(B,G–O)). The gene discussed is MGMT; the disease is glioblastoma.